Research also has shown that a significant percentage of people stop taking the medications after one year due to side effects, Carroll noted
Consequently, maximum weight loss effects are not observed until patients reach and maintain their target maintenance dose for several months
Add the bacteriostatic water, the insulin syringes, the wastage from mis-draws and dead volume, and the time spent reconstituting and calculating, and the apparent saving narrows quickly
CVOT trial will help determine if tirzepatide can demonstrate superior cardiovascular safety and potential additional cardiovascular benefits compared to the currently approved GLP-1RA dulaglutide
Lean mass loss with GLP-1 medicines is generally proportional to total weight lost, about 25 to 30 percent, similar to other weight-loss interventions, and physical function and quality of life improve